Balance Sheet
Cash Flow Statement
Beginning Cash BalanceGains from Sales and Divestitures
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RedHill Biopharma (RDHL) Depreciation and Depletion: 2012-2022

Historic Depreciation and Depletion for RedHill Biopharma (RDHL) over the last 11 years, with Dec 2022 value amounting to $491,000.

  • RedHill Biopharma's Depreciation and Depletion rose 9.35% to $491,000 in Q4 2022 from the same period last year, while for Dec 2022 it was $2.1 million, marking a year-over-year increase of 11.66%. This contributed to the annual value of $588,000 for FY2024, which is 59.31% down from last year.
  • According to the latest figures from Q4 2022, RedHill Biopharma's Depreciation and Depletion is $491,000, which was down 0.00% from $491,000 recorded in Q3 2022.
  • RedHill Biopharma's Depreciation and Depletion's 5-year high stood at $617,000 during Q2 2022, with a 5-year trough of $22,000 in Q1 2018.
  • Over the past 3 years, RedHill Biopharma's median Depreciation and Depletion value was $482,000 (recorded in 2020), while the average stood at $479,917.
  • Its Depreciation and Depletion has fluctuated over the past 5 years, first decreased by 15.38% in 2018, then surged by 1,209.09% in 2019.
  • Quarterly analysis of 5 years shows RedHill Biopharma's Depreciation and Depletion stood at $23,000 in 2018, then spiked by 1,000.00% to $253,000 in 2019, then skyrocketed by 86.96% to $473,000 in 2020, then decreased by 5.07% to $449,000 in 2021, then grew by 9.35% to $491,000 in 2022.
  • Its Depreciation and Depletion was $491,000 in Q4 2022, compared to $491,000 in Q3 2022 and $617,000 in Q2 2022.